Variations of proline-rich kinase Pyk2 expression correlate with prostate cancer progression

被引:41
|
作者
Stanzione, R
Picascia, A
Chieffi, P
Imbimbo, C
Palmieri, A
Mirone, V
Staibano, S
Franco, R
De Rosa, G
Schlessinger, J
Tramontano, D
机构
[1] Univ Naples Federico II, Dipartimento Biol & Patol Mol & Cellulare Luigi C, I-80131 Naples, Italy
[2] Univ Naples Federico II, Ctr Endocrinol & Oncol Sperimentale, CNR, I-80131 Naples, Italy
[3] Univ Naples Federico II, Urol Clin, I-80131 Naples, Italy
[4] Univ Naples Federico II, Dipartimento Sci Biomorfol & Funz, Sez Patol, I-80131 Naples, Italy
[5] Univ Sannio, Fac Sci, Benevento, Italy
[6] Univ Catanzaro Magna Graecia, Dipartimento Med Sperimentale & Clin Gaetano Salv, Catanzaro, Italy
[7] NYU Med Ctr, Dept Pharmacol, New York, NY 10016 USA
关键词
D O I
10.1038/labinvest.3780211
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Proline-rich kinase 2 (Pyk2), also known as CAK beta (cell adhesion kinase beta), is a cytoplasmic tyrosine kinase that is structurally related to focal adhesion kinase. Pyk2 is expressed in different cell types including brain cells, fibroblasts, platelets, and other hemopoietic cells. Pyk2 is rapidly tyrosine phosphorylated in response to diverse extracellular signals acting via different post receptor pathways. We have investigated whether this protein kinase is functionally expressed in normal and neoplastic prostate tissues. In this study, we demonstrate that Pyk2 is expressed only in normal epithelial prostate tissue and in benign prostatic hyperplasia, whereas its expression progressively declines with an increasing grade of malignancy of prostate cancer.
引用
收藏
页码:51 / 59
页数:9
相关论文
共 50 条
  • [21] The role of proline-rich Protein tyrosine kinase 2 (Pyk2) in differentiation-dependent signaling in normal human keratinocytes
    Schindler, E. M.
    Baumgartner, M.
    Efimova, T.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 : 60 - 60
  • [22] Proline-rich tyrosine kinase 2 (Pyk2), a focal adhesion kinase (FAK) homologue, induces apoptosis in human malignant metastatic melanoma
    Chang, S. K.
    Hindes, A.
    Cornelius, L. A.
    Efimova, T.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2012, 132 : S130 - S130
  • [23] TNF-α activates proline-rich tyrosine kinase 2 (PYK2) in pancreatic acinar cells by protein kinase C dependent mechanism
    Satoh, A
    Daghighian, MS
    Reeve, JR
    Pandol, SJ
    Gukovskaya, AS
    GASTROENTEROLOGY, 2004, 126 (04) : A529 - A530
  • [24] Proline-Rich Tyrosine Kinase 2 (Pyk2) Promotes Cell Motility of Hepatocellular Carcinoma through Induction of Epithelial to Mesenchymal Transition
    Sun, Chris K.
    Ng, Kevin T.
    Lim, Zophia X.
    Cheng, Qiao
    Lo, Chung Mau
    Poon, Ronnie T.
    Man, Kwan
    Wong, Nathalie
    Fan, Sheung Tat
    PLOS ONE, 2011, 6 (04):
  • [25] Non-receptor type, proline-rich protein tyrosine kinase 2 (Pyk2) is a possible therapeutic target for Kawasaki disease
    Suzuki, Chinatsu
    Nakamura, Akihiro
    Miura, Noriko
    Fukai, Kuniyoshi
    Ohno, Naohito
    Yahata, Tomoyo
    Okamoto-Hamaoka, Akiko
    Fujii, Maiko
    Yoshioka, Ayako
    Kuchitsu, Yuki
    Ikeda, Kazuyuki
    Hamaoka, Kenji
    CLINICAL IMMUNOLOGY, 2017, 179 : 17 - 24
  • [26] The proline-rich tyrosine kinase Pyk2 modulates integrin-mediated neutrophil adhesion and reactive oxygen species generation
    Canino, Jessica
    Guidetti, Gianni Francesco
    Galgano, Luca
    Vismara, Mauro
    Minetti, Giampaolo
    Torti, Mauro
    Canobbio, Ilaria
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2020, 1867 (10):
  • [27] Sulfoximine-substituted trifluoromethylpyrimidine analogs as inhibitors of proline-rich tyrosine kinase 2 (PYK2) show reduced hERG activity
    Walker, Daniel P.
    Zawistoski, Michael P.
    McGlynn, Molly A.
    Li, Jian-Cheng
    Kung, Daniel W.
    Bonnette, Peter C.
    Baumann, Amy
    Buckbinder, Leonard
    Houser, Janet A.
    Boer, Jason
    Mistry, Anil
    Han, Seungil
    Xing, Li
    Guzman-Perez, Angel
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (12) : 3253 - 3258
  • [28] A new role for proline-rich tyrosine kinase 2 (Pyk2) in polymorphonuclear leukocyte adhesive responses triggered by P-selectin
    Federico, L
    Manarini, S
    Panchatcharam, M
    Pamuklar, Z
    Rojas, M
    Evangelista, V
    Smyth, SS
    FASEB JOURNAL, 2006, 20 (04): : A225 - A225
  • [29] Role of proline-rich tyrosine kinase 2 (PYK2) in dexamethasone (DEX)-induced apoptosis in multiple myeloma (MM) cells.
    Chauhan, D
    Hideshima, T
    Pandey, P
    Treon, SP
    Teoh, G
    Raje, N
    Kufe, DW
    Okada, H
    Kharbanda, S
    Anderson, KC
    BLOOD, 1998, 92 (10) : 636A - 636A
  • [30] The Role of Proline Rich Tyrosine Kinase 2 (Pyk2) on Cisplatin Resistance in Hepatocellular Carcinoma
    Geng, Wei
    Ng, Kevin T. P.
    Sun, Chris K. W.
    Yau, Wing Lung
    Liu, Xiao Bing
    Cheng, Qiao
    Poon, Ronnie T. P.
    Lo, Chung Mau
    Man, Kwan
    Fan, Sheung Tat
    PLOS ONE, 2011, 6 (11):